Financials
Income statement
| Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|
| Total reported revenue | 7.9B | 8.0B | 7.9B | 7.3B |
| Cost of revenue | 5.6B | 5.5B | 5.6B | 5.2B |
| Gross profit | 2.3B | 2.5B | 2.3B | 2.1B |
| Operating expense | ||||
| Research & development | — | — | — | — |
| Selling general and admin | — | — | — | — |
| Other operating expenses | — | — | — | — |
| Operating income | 154M | 312M | 109M | -25M |
| Non operating interest income | ||||
| Income | 49M | 53M | 55M | 53M |
| Expense | 23M | 40M | 36M | 37M |
| Other income expense | 36M | -46M | 4M | 12M |
| Pretax income | 216M | 279M | 132M | 3M |
| Tax provision | 102M | 148M | 68M | 108M |
| Net income | 114M | 131M | 64M | -105M |
| Basic EPS | 0.1 | 0.1 | 0.0 | 0.0 |
| Diluted EPS | 0.1 | 0.1 | 0.0 | 0.0 |
| Basic average shares | 1.8B | 1.8B | 1.8B | 1.8B |
| Diluted average shares | 1.8B | 1.8B | 1.8B | 1.8B |
| EBITDA | 361M | 439M | 280M | 146M |
| Net income from continuing op. | 114M | 131M | 64M | -105M |
| Minority interests | -7M | 25M | 6M | 28M |
| Preferred stock dividends | — | — | — | — |